Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects

Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects
复制标题

DOI:
10.2337/diabetes.53.3.624
复制
发表时间:
2004-03-01
期刊:
影响因子:
7.7
通讯作者:
Markmann, JF
Markmann, JF
中科院分区:
医学1区
文献类型:
--
作者:
Deng, SP;Vatamaniuk, M;Markmann, JF

文献摘要

被引文献

相似文献

2型糖尿病患者既存在胰岛素作用紊乱,其胰岛细胞也有异常。后者究竟是原发性缺陷还是前者的结果尚不清楚。为了直接检测2型糖尿病患者胰岛的β细胞数量和功能,我们从2型糖尿病尸体捐赠者(n = 14)的胰腺中分离出胰岛,并将其与年龄、体重指数和冷缺血时间相匹配的正常捐赠者(n = 14)的胰岛进行比较。从2型糖尿病胰腺中回收的胰岛总量明显少于非糖尿病对照组(256,260个胰岛当量[2,588 IEq/克胰腺]对比597,569个胰岛当量[6,037 IEq/克胰腺])。还注意到2型糖尿病胰岛平均较小,从组织学上看,糖尿病患者的胰岛中产生胰高血糖素的α细胞比例较高。对糖尿病患者胰岛功能的体外研究显示,在灌流实验中,葡萄糖刺激的胰岛素释放反应异常。此外,与正常胰岛相比,相同数量的2型糖尿病胰岛移植到免疫缺陷型糖尿病小鼠体内时无法逆转高血糖。这些结果为2型糖尿病患者胰岛的异常提供了直接证据,这些异常可能导致该疾病的发病机制。
Type 2 diabetic subjects manifest both disordered insulin action and abnormalities in their pancreatic islet cells. Whether the latter represents a primary defect or is a consequence of the former is unknown. To examine the beta-cell mass and function of islets from type 2 diabetic patients directly, we isolated islets from pancreata of type 2 diabetic cadaveric donors (n = 14) and compared them with islets from normal donors (n = 14) matched for age, BMI, and cold ischemia time. The total recovered islet mass from type 2 diabetic pancreata was significantly less than that from nondiabetic control subjects (256,260 islet equivalents [2,588 IEq/g pancreas] versus 597,569 islet equivalents [6,037 IEq/g pancreas]). Type 2 diabetic islets were also noted to be smaller on average, and histologically, islets from diabetic patients contained a higher proportion of glucagon-producing alpha-cells. In vitro study of islet function from diabetic patients revealed an abnormal glucose-stimulated insulin release response in perifusion assays. In addition, in comparison with normal islets, an equivalent number of type 2 diabetic islets failed to reverse hyperglycemia when transplanted to immunodeficient diabetic mice. These results provide direct evidence for abnormalities in the islets of type 2 diabetic patients that may contribute to the pathogenesis of the disease.